Evidence map›Paper›PMID 28082432›Full record

ReviewJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017

Quantification of Lung PET Images: Challenges and Opportunities.

Delphine L Chen, Joseph Cheriyan, Edwin R Chilvers, Gourab Choudhury, Christopher Coello, Martin Connell, Marie Fisk, Ashley M Groves, Roger N Gunn, Beverley F Holman and 13 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. PulmonaryEuropean journal of nuclear medicine and molecular imaging · 2018
    Trial
  3. Pulmonary [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Exploratory evaluation of earlyEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Article
  6. HighERJ open research · 2026
    Article
  7. Effect of probenecid on the whole-body disposition of 6-bromo-7-[European journal of nuclear medicine and molecular imaging · 2025
    Article
  8. Prognostic value of [Scientific reports · 2025
    Article
  9. Article
  10. Review
  11. High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. 2-deoxy-2-[Molecular imaging and biology · 2023
    Article
  16. Review
  17. High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  18. Quantitative imaging in medicine and surgery · 2023
    Article
  19. Article
  20. Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 2 countries.

Delphine L ChenMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri chend@wustl.edu.
Joseph CheriyanDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Edwin R ChilversDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Gourab ChoudhuryQueen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Christopher CoelloImanova Ltd., London, United Kingdom.
Martin ConnellQueen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Marie FiskDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Ashley M GrovesInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Roger N GunnImanova Ltd., London, United Kingdom.
Beverley F HolmanInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Brian F HuttonInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Sarah LeeMedical Image Analysis Consultant, London, United Kingdom.
William MacNeeQueen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Divya MohanClinical Discovery, Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, Pennsylvania.
David ParrUniversity Hospitals Coventry and Warwickshire, Coventry, United Kingdom.
Deepak SubramanianDerby Teaching Hospitals NHS Foundation Trust, Derby, United Kingdom.
Ruth Tal-SingerClinical Discovery, Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, Pennsylvania.
Kris ThielemansInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Edwin J R van BeekQueen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Laurence VassDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Jeremy W WellenWorldwide Research and Development, Pfizer, Inc., Cambridge, Massachusetts; and.
Ian WilkinsonDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Frederick J WilsonExperimental Medicine Imaging, GlaxoSmithKline, Stevenage, United Kingdom.
University College London · GBUniversity of Cambridge · GBGlaxoSmithKline (United States) · USThe Queen's Medical Research Institute · GBUniversity of Edinburgh · GBCambridge University Hospitals NHS Foundation Trust · GBGlaxoSmithKline (United Kingdom) · GBImperial College London · GBInstitute of Group Analysis · GBMallinckrodt (United States) · USPfizer (United States) · USUniversity Hospitals Coventry and Warwickshire NHS Trust · GB

Funding

POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANTR01HL121218 · NHLBI · WASHINGTON UNIVERSITY · PI CHEN, DELPHINE L, GELMAN, ANDREW ERIC · 2014 to 2017
$2.8M
British Heart Foundation FS/12/8/29377Medical Research Council MR/J00345X/1NHLBI NIH HHS R01 HL121218
6 · The paper itself

Abstract

Millions of people are affected by respiratory diseases, leading to a significant health burden globally. Because of the current insufficient knowledge of the underlying mechanisms that lead to the development and progression of respiratory diseases, treatment options remain limited. To overcome this limitation and understand the associated molecular changes, noninvasive imaging techniques such as PET and SPECT have been explored for biomarker development, with

Indexed as

Fluorodeoxyglucose F18HumansImage Interpretation, Computer-AssistedLungLung DiseasesPositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsRespiratory Function TestsSensitivity and SpecificityFluorodeoxyglucose F18Radiopharmaceuticalslung inflammationmolecular imagingpositron emission tomographypulmonary

Identifiers

PMID28082432
PMCPMC5288738
OpenAlexW2574580190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.